Other studies have demonstrated that anti-depressants, including tricyclics and selective 5-HT reuptake inhibitors, could markedly improve the symptoms of patients with chronic fatigue syndrome (5, 22). The gene discussed is HTR5A; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.